Evidence map›Paper›PMID 28324627›Full record

Trial reportThe American journal on addictions2017

Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge.

Christina S Lee, Jane M Liebschutz, Bradley J Anderson, Michael D Stein

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal on addictions, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04650386 (Enhancing Office-based Buprenorphine Treatment), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04650386 nacompletednot on this mapstarted 2020, after this paper: background citation

Enhancing Office-based Buprenorphine Treatment: An Adaptive Psychosocial Approach

TypeinterventionalSponsorPublic Health Management CorporationRan2020 to 2024Enrolled125ConditionsOpioid-use DisorderArmsPsychosocial support determined by adaptive treatment algorithm
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Routes of non-traditional entry into buprenorphine treatment programs.Substance abuse treatment, prevention, and policy · 2020
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Christina S LeeBouvé College of Health Sciences, Northeastern University, Boston, Massachusetts.ORCID http://orcid.org/0000-0002-2278-9888
Jane M LiebschutzClinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, Massachusetts.
Bradley J AndersonDepartment of Behavioral Medicine, Butler Hospital, Providence, Rhode Island.
Michael D SteinDepartment of Behavioral Medicine, Butler Hospital, Providence, Rhode Island.
Boston University · USNortheastern University · USProvidence College · US

Funding

Linkage of Hospitalized Opioid Users to BuprenorphineR01DA026223 · NIDA · BUTLER HOSPITAL (PROVIDENCE, RI) · PI STEIN, MICHAEL D · 2009 to 2013
$1.7M
NIDA NIH HHS R01 DA026223
6 · The paper itself

Abstract

objectivesFew studies have explored predictors of entry into and retention in buprenorphine treatment following linkage from an acute medical hospitalization.

methodsThis secondary analysis of a completed clinical trial focuses on medically hospitalized, opioid-dependent patients (n = 72) who were randomized to an intervention including buprenorphine induction and dose stabilization during hospitalization followed by post-discharge transition to office-based buprenorphine treatment (OBOT). Predictors included demographics, days hospitalized, prior buprenorphine/methadone treatment, PTSD symptoms, social support, and readiness for drug use cessation. Outcome variables were treatment entry and retention (number of days in OBOT).

resultsPrevious buprenorphine treatment, more days hospitalized, and higher PTSD symptoms predicted OBOT entry. Prior treatment, older age, and non-minority status were associated with a higher mean number of days in OBOT.

conclusionsOBOT may appeal to patients who have tried buprenorphine in other settings. Linking hospitalized patients to OBOT may improve utilization of addiction treatment. SCIENTIFIC SIGNIFICANCE: Prior substance treatment, longer hospital stay, and mental health should be examined in future linkage studies. (Am J Addict 2017;26:667-672).

Indexed as

BuprenorphineOpioid-Related DisordersAdultContinuity of Patient CareFemaleHospitalizationHumansMaleMethadoneMiddle AgedNarcotic AntagonistsOpiate Substitution TreatmentPatient DischargePatient DropoutsRisk FactorsTreatment OutcomeBuprenorphineMethadoneNarcotic Antagonists

Identifiers

PMID28324627
PMCPMC5608622
OpenAlexW2600267617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.